Taylor J - Search Results

1

Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men.

Randell PA, Jackson AG, Boffito M, Back DJ, Tjia JF, Taylor J, Mandalia S, Moyle GJ. Randell PA, et al. Among authors: taylor j. Antivir Ther. 2010;15(8):1125-32. doi: 10.3851/IMP1675. Antivir Ther. 2010. PMID: 21149919 Clinical Trial.

2

Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation.

Boffito M, Else L, Back D, Taylor J, Khoo S, Sousa M, Pozniak A, Gazzard B, Moyle G. Boffito M, et al. Among authors: taylor j. Antivir Ther. 2008;13(7):901-7. Antivir Ther. 2008. PMID: 19043924 Clinical Trial.

3

Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.

Jackson A, Moyle G, Dickinson L, Back D, Khoo S, Taylor J, Gedela K, Abongomera G, Gazzard B, Boffito M. Jackson A, et al. Among authors: taylor j. Antivir Ther. 2012;17(1):19-24. doi: 10.3851/IMP1910. Antivir Ther. 2012. PMID: 22267465 Free PMC article. Clinical Trial.

4

Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteers.

Boffito M, Jackson A, Lamorde M, Back D, Watson V, Taylor J, Waters L, Asboe D, Gazzard B, Pozniak A. Boffito M, et al. Among authors: taylor j. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):222-7. doi: 10.1097/QAI.0b013e3181b061d0. J Acquir Immune Defic Syndr. 2009. PMID: 19620877 Clinical Trial.

5

Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

Jackson A, D'Avolio A, Watson V, Bonora S, Back D, Taylor J, Armenis K, Gazzard B, Moyle G, Boffito M. Jackson A, et al. Among authors: taylor j. J Antimicrob Chemother. 2011 Apr;66(4):885-9. doi: 10.1093/jac/dkq546. Epub 2011 Jan 22. J Antimicrob Chemother. 2011. PMID: 21393207 Clinical Trial.

6

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.

Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, Khoo S, Back D, Orrell C, Clarke A, Losso M, Phanuphak P, Carey D, Cooper DA, Emery S, Puls R; ENCORE1 Study Group. Dickinson L, et al. Clin Pharmacol Ther. 2015 Oct;98(4):406-16. doi: 10.1002/cpt.156. Epub 2015 Jul 14. Clin Pharmacol Ther. 2015. PMID: 26044067 Free PMC article. Clinical Trial.

7

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

Paton NI, Goodall RL, Dunn DT, Franzen S, Collaco-Moraes Y, Gazzard BG, Williams IG, Fisher MJ, Winston A, Fox J, Orkin C, Herieka EA, Ainsworth JG, Post FA, Wansbrough-Jones M, Kelleher P; Hydroxychloroquine Trial Team. Paton NI, et al. JAMA. 2012 Jul 25;308(4):353-61. doi: 10.1001/jama.2012.6936. JAMA. 2012. PMID: 22820788 Free PMC article. Clinical Trial.

8

Sum-frequency vibrational spectroscopy, a tutorial: Applications for the study of lipid membrane structure and dynamics.

Taylor JM, Conboy JC. Taylor JM, et al. Biointerphases. 2024 May 1;19(3):031201. doi: 10.1116/6.0003594. Biointerphases. 2024. PMID: 38738942 Review.

9

Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study.

Röttgering JG, Taylor JW, Brie M, Luks T, Hervey-Jumper SL, Phan S, Bracci PM, Smith E, De Witt Hamer PC, Douw L, Weyer-Jamora C, Klein M. Röttgering JG, et al. Among authors: taylor jw. Neurooncol Pract. 2024 Feb 9;11(3):284-295. doi: 10.1093/nop/npae011. eCollection 2024 Jun. Neurooncol Pract. 2024. PMID: 38737609 Free PMC article.

10

Antibullying Interventions in Schools: Assessing the Evidence Base.

George P, Cosgrove J, Taylor J, Rao N, Marshall T, Ghose SS, Patel NA. George P, et al. Among authors: taylor j. Psychiatr Serv. 2024 May 13:appips20230541. doi: 10.1176/appi.ps.20230541. Online ahead of print. Psychiatr Serv. 2024. PMID: 38736361 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,939 results

Search Page